Hepatic gluconeogenic pathway

The hepatic gluconeogenic pathway is a critical metabolic process in the liver that generates glucose from non-carbohydrate precursors, including lactate, glycerol, and amino acids, especially during fasting, starvation, or intense physical activity. It involves several enzymes, such as pyruvate carboxylase, phosphoenolpyruvate carboxykinase, and glucose-6-phosphatase, and is tightly regulated by hormones like insulin (which suppresses gluconeogenesis) and glucagon/cortisol (which stimulate the process). The pathway is essential for maintaining normal blood glucose levels and supporting organs that depend on glucose as an energy source (e.g., brain, erythrocytes). Dysregulation of hepatic gluconeogenesis contributes to diabetes and is a target for pharmacological intervention via its individual enzymes. In summary, "Hepatic gluconeogenic pathway" is a physiological process, not a discrete molecule or therapeutic target. For drug discovery or therapeutic focus, it is necessary to specify particular enzymes or regulatory proteins within the pathway, such as "phosphoenolpyruvate carboxykinase" or "glucose-6-phosphatase" as the canonical targets.

Other names

GluconeogenesisLiver gluconeogenesisEndogenous glucose production

Not applicable to the pathway as a whole. For drugs against pathway components: Inhibition of key gluconeogenic enzymes (e.g., pyruvate carboxylase, phosphoenolpyruvate carboxykinase); Modulation of hormone signaling (insulin inhibits; glucagon and cortisol stimulate)